Actelion to discuss full year 2012 financial results

For best results when printing this announcement, please click on the link below:

http://pdf.reuters.com/htmlnews/8knews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130208:nHUGcW57

Actelion Pharmaceuticals Ltd / Actelion to discuss full year 2012 financial results . Processed
and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this
announcement.

Dear member of the investment community

Actelion Ltd will announce its full year results 2012 financial results on Thursday, 14 February
2013, at 07.00 hrs CET / 06.00 hrs GMT / 01.00 a.m. EDT. An investor conference call & webcast
will be held at 14.00 hrs, CET.

Date/Time:

14 February 2013 14.00 hrs - 15.00 hrs Basel (CET) 13.00 hrs - 14.00 hrs UK (GMT) 08.00 a.m. - 09.00 a.m. US (EST)

14 February 2013

14.00 hrs - 15.00 hrs

Basel (CET)

13.00 hrs - 14.00 hrs

UK (GMT)

08.00 a.m. - 09.00 a.m.

US (EST)

Conference Call Connect #:

Dial-in participants should start calling the number below 10-15 minutes before the conference is
due to start.

Dial: Europe: +41 (0)44 580 00 74 UK: +44 (0)203 367 94 54 US: +1 866 907 59 24

Dial:

Europe:

+41 (0)44 580 00 74

UK:

+44 (0)203 367 94 54

US:

+1 866 907 59 24

Participant's mode:

Listen-Only with possibility to open individual lines during Q&A session.
Participants will be asked for their Name and Company.

Webcast Access:

Webcast participants should visit the Actelion website http://www.actelion.com
http://www.actelion.com/ 10-15 minutes before the conference is due to start.

Participant's mode:

Listen-Only

Webcast Replay:

The archived Investor Webcast will be available for replay through http://www.actelion.com
http://www.actelion.com/ / approximately 60 minutes after the call has ended.

Press Release PDF http://hugin.info/131801/R/1676747/546626.pdf

----------------------------------------------------------------------------------------------------

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: Actelion Pharmaceuticals Ltd via Thomson Reuters ONE

HUG#1676747

--- End of Message ---

Actelion Pharmaceuticals Ltd
Gewerbestrasse 16 Allschwil Switzerland

ISIN: CH0010532478;